Scientists at the Ruđer Bošković Institute (RBI) in Zagreb, Croatia, have discovered that the protein CENP-E, long believed ...

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest forms of breast cancer to treat, but a new ...

Mayo Clinic researchers collaborated on a new study led by Eli Lilly showing that the drug abemaciclib improves survival for ...

A Weill Cornell Medicine team has found that triple-negative breast cancer depends on the enzyme EZH2 to spread. By silencing ...

ROCHESTER, Minn. — Mayo Clinic researchers, in collaboration with Eli Lilly, have found that the drug abemaciclib ...

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from ...

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown — only a few risk factors ...

Researchers believe a groundbreaking new drug can offer hope to those diagnosed with this deadly breast cancer, creating a ...

Dr. Matthew Matasar discusses why stem cell transplant is still a standard, life-saving option in blood cancers and how CAR-T ...

Patients with recurrent or metastatic squamous cell carcinoma (HNSCC), who had markers showing they would likely respond to ...